Viewing Study NCT00002560


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-30 @ 7:41 AM
Study NCT ID: NCT00002560
Status: COMPLETED
Last Update Posted: 2013-06-28
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module